Site Search
Professionals 690 results
Capabilities 88 results
Region
Winston’s deep experience representing companies and investors across Latin America and the Caribbean has made the firm a “go-to” resource for the strategic development of our clients’ businesses and the vigorous protection of their interests in the region. With broad command of a diverse range of issues within the region’s key industry sectors, we advise Fortune 500 companies, government and quasi-governmental entities, financial institutions, private equity and other investors, domestic and international oil and gas exploration and production companies, refiners and shippers, and a range of commercial and infrastructure developers.
Industry
Insurance plays an essential role in risk mitigation for financial services companies. As risks evolve, questions often arise concerning the scope of insurance coverage and the interpretation and application of policy provisions. Winston’s insurance lawyers provide companies with best-in-class advice, corporate and transactional counsel, and, if need be, litigation defense in high-stakes coverage disputes and class actions. We have achieved excellent outcomes for our clients in matters involving a wide variety of insurance policies and claims, including cybersecurity, travel, long-term care, and annuities, among others. Moreover, we have experience in emerging issues and industries, such as blockchain technology and artificial intelligence, both of which present insurers with a unique and complicated set of risks and opportunities.
Industry
Winston is well regarded for deep and broad experience advising clients in the development, construction, financing and refinancing, acquisition, and operation of major infrastructure assets, including several award-winning deals and public-private-partnership (PPPs or P3s) projects in North America, Latin America, and Europe. Recognized for our ability to “take complex issues and boil them down to pragmatic solutions” (Chambers USA 2023), our team represents a diverse mix of participants and stakeholders in a broad range of investments and non-recourse/limited recourse financings, and we have experience working on many of the most complex projects, within aggressive time frames, while employing inventive solutions. Likewise, our lawyers help to identify and quantify roadblocks and risks at an early stage, so that we can help our clients—which include developers and sponsors, a full range of lenders and investors, project owners and operators, governments and their agencies, and other project counterparties—evaluate and, to the extent possible, mitigate or eliminate risk.
Experience 403 results
Experience
|November 11, 2024
Experience
|November 8, 2024
GSR III Acquisition Corp. Announces the Closing of its $230.0 Million Initial Public Offering
Insights & News 7,546 results
Sponsorship
|November 25, 2024
Winston & Strawn Co-Hosts NextGen Judicial Panel
Winston & Strawn is proud to co-host a judicial panel discussion with The Next Generation Lawyers Group, Berkeley Center for Law & Technology, and the ABA Antitrust Unilateral Conduct Committee, during which three judges will provide advice for young lawyers on their development as advocates and as professionals.
Benefits Blast
|November 20, 2024
|2 Min Read
The Internal Revenue Service Health and Welfare Limits for 2025
The Internal Revenue Service recently published limits for 2025 in Revenue Procedure 2024-40. Below we have outlined health and welfare limits for 2025 and the changes in those limits from 2024.
Sponsorship
|November 19, 2024
Winston’s Financial Services Industry Group is a proud sponsor of the Tenth Annual Government Investigations & Civil Litigations Institute (GICLI) Meeting in Fort Lauderdale, FL.
Other Results 71 results
Site Content
What Is a Delaware Corporation?
A Delaware corporation is a company that is formed in the state of Delaware but can conduct business anywhere. Incorporating in Delaware has become widespread among large U.S. companies, including more than half of the S&P 500.
Law Glossary
What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?
Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262.